Compound Specifications
Tesamorelin + Ipamorelin combines two peptide components in one lyophilized research vial. The current batch is documented with independent Janoshik amount/composition and endotoxin reports. Research compound — not for human use.
Product Details
- Compound: Tesamorelin + Ipamorelin
- Declared contents: Tesamorelin 10mg + Ipamorelin 3mg
- Verified composition: Tesamorelin 9.12mg + Ipamorelin 2.87mg
- Testing: Batch-specific Janoshik amount/composition and endotoxin reports are published for batch PP2603-055
- Form: Lyophilized powder
- Testing: View COA (Verified by Janoshik Analytical) →
Tesamorelin + Ipamorelin documentation
Review the current batch documentation before comparing the catalog record with published laboratory literature.
- Batch: PP2603-055.
- Independent reports: Janoshik tasks 212680 and 212682.
- Documentation: view the Tesamorelin + Ipamorelin COA record and Quality & Testing.
Research use only. This page does not provide dosing, administration, reconstitution, treatment, or human-use guidance.

